TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CHASING CURES. DELIVERING HOPE.

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CHASING CURES. DELIVERING HOPE.

ST13

US500000079397997

Classe

5, 10, 42

Pedido

79397997

Registro

7797603

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

30

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 42

Data de depósito

22/02/2024

Data de registro

20/05/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/05/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

London, GB

Examinador

HUDSON, TAMARA BREE

Unidade examinadora

L40

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Aviadobio Ltd
Aviadobio Ltd

Representantes

Matthew J. Snider Dickinson Wright PLLC

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical and biotechnological preparations and substances being pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; drug delivery agents consisting of compounds, namely, liposomes and viral particles that facilitate delivery of a wide range of pharmaceuticals

Classe 10

Medical instruments and apparatus for use in surgery; medical instruments and apparatus, namely, clamps for surgical use, surgical retractors, surgical platforms, surgical stabilizers, and surgical manipulator arms; medical diagnostic instruments and apparatus for the diagnosis of neurological diseases and disorders, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological diseases and disorders, sold without medication; implantable drug delivery devices, namely, implantable drug delivery pumps and implantable drug delivery ports

Classe 42

Scientific and technological services, namely, research and design in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; design and development of computer hardware and software; scientific research and development, biological research and development, clinical research and development, medical research and development; research, development and testing relating to pharmaceutical and biotechnological preparations and substances; research, development and testing relating to medical and scientific instruments and apparatus; research, development and testing relating to neurological therapeutics, diseases and disorders; design and development of medical diagnostic apparatus; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical and biotechnological preparations and substances; scientific research in the nature of conducting clinical trials for others in the fields of neurological therapeutics, diseases and disorders; scientific research in the nature of conducting clinical trials for others in the fields of medical and scientific instruments and apparatus; providing online, non-downloadable software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for analysing clinical information; providing online, non-downloadable software for diagnosis of neurological diseases and disorders; providing online, non-downloadable software for operating medical instruments and apparatus; providing online, non-downloadable software for connecting machines and medical instruments and apparatus; providing online, non-downloadable software for collecting and exchanging information and data; providing online, non-downloadable software for monitoring medical instruments and apparatus and interfacing with the cloud; providing online, non-downloadable software for mobile devices, smartphones, tablet computers, personal computers and televisions for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for transmitting, sharing, receiving, streaming, downloading, playing, organizing, displaying, collecting and transferring information, data, audio, video, images, content and other multimedia content between devices via the internet, over a wireless network and other communications networks; providing online, non-downloadable software for the remote control of machines and medical instruments and apparatus; providing online, non-downloadable software for facilitating cloud computing services; information technology services, namely, technical consulting services relating to the technology fields of medical and scientific instruments and apparatus; information technology services, namely, technical consulting services relating to the technology fields of pharmaceutical and biotechnological preparations and substances; advisory and consulting services related to the aforegoing services

Publicações

Histórico de despachos e eventos da marca no USPTO.

30 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/01/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

17/12/2025

FIMP

FINAL DISPOSITION PROCESSED

17/12/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/12/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

19/11/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

19/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

20/08/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

20/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

20/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/04/2025

PUBO

PUBLISHED FOR OPPOSITION

01/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

10/03/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/03/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

10/03/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

14/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

14/02/2025

RFNT

REFUSAL PROCESSED BY IB

07/10/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/09/2024

RFRR

REFUSAL PROCESSED BY MPU

16/09/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

14/09/2024

CNRT

NON-FINAL ACTION WRITTEN

13/09/2024

DOCK

ASSIGNED TO EXAMINER

11/09/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/08/2024

MAFR

APPLICATION FILING RECEIPT MAILED

21/06/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

21/06/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

20/06/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CHASING CURES. DELIVERING HOPE. ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.